BOOSTRIX: Syringes may be cracked in affected lot.
Last updated
Summary
Product
BOOSTRIX
Issue
Health products - Product quality
What to do
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
BOOSTRIX |
BOOSTRIX |
DIN 02247600 |
Suspension for injection |
DIPHTHERIA TOXOID 2 UNIT / 0.5 ML, FILAMENTOUS HAEMAGGLUTININ 8 MCG / 0.5 ML, PERTACTIN 2.5 MCG / 0.5 ML, PERTUSSIS TOXOID 8 MCG / 0.5 ML, TETANUS TOXOID 20 UNIT / 0.5 ML |
2259Z |
Issue
Syringes may be cracked in affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesale, Healthcare Establishments, Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Biologic or vaccine
Companies
GlaxoSmithKline Inc.
100 Milverton Drive, Suite 800, Mississauga
ON, L5R 4H1
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-64605
Get notified
Receive notifications for new and updated recalls and alerts by category.